Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings

7

June 29 (Reuters) – The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that supported approval of Amgen’s rare-disease drug, citing concerns that patient

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)